awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26795556-63424C22-F853-426D-A3BC-6D623A0A56D8
Q26795556-63424C22-F853-426D-A3BC-6D623A0A56D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26795556-63424C22-F853-426D-A3BC-6D623A0A56D8
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application
P2860
Q26795556-63424C22-F853-426D-A3BC-6D623A0A56D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26795556-63424C22-F853-426D-A3BC-6D623A0A56D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a293d27d875a4232ae0357c53a2db51dd3508254
P2860
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.